AG1295 化学特性,用途語,生産方法
説明
Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. Tyrphostins are a class of antiproliferative compounds which act as PTK blockers. PTK inhibitors specific for platelet-
derived growth factor (PDGF) receptor kinase could help in the treatment of atherosclerosis, restenosis, pulmonary fibrosis, and gliomas. AG-
1295 is a quinoxaline-
type tyrphostin that acts as a potent and selective inhibitor of PDGF receptor kinase
in vitro and in Swiss 3T3 cells (IC
50s range from 0.3-
1 μM). It inhibits PDGF-
stimulated DNA synthesis with an IC
50 value of 2.5 μM without affecting activity of the EGF receptor.
使用
AG-1295 is a protein tyrosine kinase inhibitor. Antiproliferative agent used in the treatment of atherosclerosis, pulmonary fibrosis, and gliomas.
AG1295 上流と下流の製品情報
原材料
準備製品